Defibrillator Market Size, Share & Trends Analysis Report By Product (Implantable Cardioverter Defibrillators (ICDs), External Defibrillators (ED)), By End User (Hospital, Pre-Hospital, Public Access Market, Alternate Care Market, Home Healthcare) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Defibrillator Market Size & Trends

The global defibrillator market size was valued at USD 11.30 billion in 2021 and is predicted to reach USD 21.09 billion by 2030, increasing at a CAGR of 7.18% from 2022 to 2030.

A defibrillator is a medical device that delivers a therapeutic shock to a patient's heart in life-threatening situations, such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. An electrical discharge to the heart depolarizes the muscles and restores the heart's normal electrical impulse as part of the defibrillation treatment. Life-saving medical devices and external defibrillators give defibrillating shocks using paddles or electrode pads to diagnose and repair life-threatening irregular heart rhythms in the case of unexpected cardiac arrest.

Increasing public and private attention to public access defibrillators (PADs) has spurred industry expansion. Additionally, the expanding geriatric population, which has an increased risk of cardiac arrest, as well as an increase in the incidence of heart disease, are all factors that contribute to the market's growth. It is possible to pace the heart with defibrillators, as well as defibrillate the patient with a device like this. It is possible to purchase a manual external defibrillator, an AED, or a portable cardioverter defibrillator as an AED (WCDs). For the treatment of SCA, AEDs are employed due to their great efficiency and ease of use, resulting in an enormous market share for defibrillators worldwide. Defibrillators market growth is being stifled by the rise in pricing pressure on companies.

Defibrillator Market Drivers

The Growing Prevalence of Cardiac Diseases Will Drive the Market

Automated external defibrillator market growth is estimated to be driven by the increased prevalence of cardiac disorders across different age groups due to demanding job circumstances, sedentary lifestyles, growing use of tobacco and alcohol, and substance abuse.

"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge" published in the International Journal of Stroke in January 2020 stated that the worldwide prevalence of atrial fibrillation was 37,574 million cases (0.51 percent of the worldwide population), which increased by 33 percent over the last 20 years. Also included in this analysis was a prediction that by the year 2050, the total number of people suffering from atrial fibrillation could rise by more than 60%. The growing burden of arrhythmia is likely to boost the expansion of the studied market over the forecast period.

A Growing Geriatric Population and The Installation of AEDs In Public Areas

Another driving force in the industry is the rise in the number of older persons. It is estimated that by 2050, the number of people aged 65 and over worldwide will rise from 727 million to more than 1.5 billion, according to the United Nations Department of Economic and Social Affairs. The proportion of the population over the age of 65 is predicted to rise from 9.3 percent in 2020 to 16.0 percent by the year 2050. Chronic disorders, such as cardiovascular disease (CVD), become more common with age.

The increased emphasis on AEDs in public areas is also contributing significantly to the market's growth. As people become more aware of the device's life-saving capabilities, more public areas, including as train stations, schools and colleges, retail centers, airports, malls and leisure centers, are installing it. Known as public access defibrillators (PADs), these devices can be used by anybody in the event of a medical crisis. Because of the increasing number of SCA incidents, a lot of countries are taking steps to install PADs in public places.

Defibrillator Market Restraints

Impeding Market Growth: Implantable and External Defibrillator Technical Issues

Defibrillators in public settings might fail owing to problems with the battery, software, or hardware. When defibrillation is not performed, it can lead to therapeutic setbacks as well as death. A number of defibrillators have been recalled in the last few years because of technical faults in the device's performance, including shock delivery, electrical issues, and hardware configurations. Poor product performance and even patient death can be the outcome of these defects.

Another key issue in the defibrillator industry is cybersecurity. Modern implantable defibrillators are highly advanced and capable of transferring data across long distances. The FDA has expressed worry about the possibility of these devices being hacked. Since its wireless telemetry equipment had no encryption or authentication safety, Medtronic was the latest corporation to face an FDA cybersecurity problem in 2019.

Market Opportunites

Innovations In the Defibrillators Market to Provide Profitable Opportunities

The Defibrillators Market is expected to grow faster than expected due to the increasing progress being made in the development of next-generation defibrillators. These Market Defibrillators are designed to help the industry better detect and address device-related problems. SCA is the world's most common cause of death, and it is a life-threatening disorder. If you intervene early and employ defibrillation, when necessary, you can successfully manage this illness. Due to rising use by heart failure patients around the world, the automated external Defibrillators Market (AEDs) presently lead the global external Defibrillators Market, which is predicted to develop at the quickest rate in the future. As the number of AEDs available to the general population has expanded, so has the demand for them. Following the market for wearable external Defibrillators, the second-largest market for external Defibrillators is for manual devices. Implantable and automated external defibrillators market difficulties, on the other hand, are likely to slow market expansion in the next years. Moreover, the development of S-ICDs and MRI-compatible ICDs & CRT-Ds are also likely to generate tremendous opportunities for the growth of the market within the forecast year.

Regional Insights

The global defibrillator market share is segmented by geography into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America Dominates the Global Market

In 2021, the revenue share held by North America was the highest, at more than 40 percent of total revenue. The expansion of the market in North America may be ascribed to several factors, including favourable legislation, initiatives taken by key companies, and technologically advanced healthcare facilities in both the United States and Canada. For example, in the year 2020, Boston Scientific said that it had sold approximately 33,000 units from their CRT-Ds line-up, which included the Resonate, Autogen, and Dynagen devices, as well as the Incepta and Cognis ones. An indication of the strong adoption rate is the fact that 16,500 of these were registered in the United States alone.

According to the Centers for Disease Control and Prevention's September 2021 report, about 659,000 people in the United States die from heart disease each year, and approximately 805,000 people have a heart attack each year, of which 605,000 suffered their first heart attack, and 200,000 people had already had one. To put it another way, this high incidence of heart attack is predicted to boost market expansion in America.

In Canada, the market for defibrillator is predicted to grow at a faster rate than the overall economy because to an increase in cardiovascular disease prevalence, increased investment in research & development, and an increased level of public knowledge about defibrillators.

Over the course of the forecast period, it is anticipated that Asia Pacific will expand at a CAGR that is the highest at 7.88 percent. This is a result of progress being made in healthcare infrastructure, a large number of patients, and the incidence of cardiovascular disorders. Because of the high penetration rate of defibrillators and the supportive legislation, the Japanese market has been at the forefront of regional expansion. In point of fact, Nihon Kohden, a market leader in Japan, documented sales of manual external defibrillators totaling more than USD 66,000 in the year 2020.

Defibrillator Market Segmental Analysis

The global defibrillator Market share is divided into different segments according to the Product, End Use, and Region (Geography).

By Product

The Global Market is segmented into Implantable Cardioverter Defibrillators (ICDs) and External Defibrillators (ED). ICDs, or implantable cardioverter defibrillators, have a market share of more than 72 percent in 2021, making them the industry standard. The increasing use of these devices as a result of the rising prevalence of cardiovascular illnesses, the high geriatric population in key economies, and the expanding product upgrades by leading businesses are the primary reasons that are driving the growth of this market segment. For example, in the year 2020, Medtronic reported ongoing acceptance and expansion of the market for its MRI-compatible Claria CRT-D devices. In addition to this, the company's Crome & Cobalt portfolio of CRT-Ds and ICDs also showed a significant amount of growth.

It is expected that the segment of external defibrillators would have the highest growth rate of 9.29 percent over the course of the forecast period. This is because to developments in technology as well as programmes encouraging access to automated external defibrillators (AEDs) in public locations. In the United Kingdom, there is a legislation being drafted to improve the accessibility and availability of automated external defibrillators (AEDs). It would become mandatory to put defibrillators at public areas if the measure is passed, which will boost the demand for automated external defibrillators (AEDs). Existence of favorable regulatory policies and initiatives by public and private health organisations to promote public access to defibrillators already exists in a number of key markets, including the United States of America, Canada, Italy, Japan, Australia, and China. Defibrillators are a life-saving medical device that can save lives.

By End Use

The global market is segmented into Hospital, Pre-Hospital, Public Access Market, Alternate Care Market, and Home Healthcare. In 2021, hospitals had the greatest revenue share, accounting for more than 75 percent of total revenue. This is due to the increased number of cardiac patients treated in hospitals as well as the increase in the number of surgical procedures performed in hospital settings. In-Core Defibrillators (ICDs) and Defibrillators Applied to the Chest (External Defibrillators) are Becoming More Commonly Used in Hospitals for the Treatment of Patients Suffering from Sudden Cardi For example, as of January 2021, Boston Scientific reported that approximately 659 thousand ICDs have been distributed across the world. When compared to the 600,000 ICDs that had been distributed as of January 2020, this number significantly grew by 59,000, demonstrating that there is a considerable demand.

The public access market segment is projected to witness the fastest growth rate of 9.58 percent over the forecast period. This is expected to be the case as a result of the rising number of initiatives to improve response times to sudden cardiac arrest events, train personnel, and increase the availability of AEDs for public access. According to a story that was published in the Global Times in January 2020, various tourist cities, first-tier cities, and coastal provinces located around China have launched expedited AED deployment since 2019. Additionally, Hangzhou was the first city in China to make it compulsory for automated external defibrillators (AEDs) to be placed at airports, railway stations, law enforcement automobiles, ships, and other public locations.

Recent Developments

• June 2022 - For biopharmaceutical firms seeking contract process development and GMP-compliant contract manufacturing, Asahi Kasei Medical has finalized the acquisition of Bionova Scientific, LLC, which was announced on April 19, 2022. On May 31, 2022, the acquisition was completed (US Pacific time). In the Bioprocess Division of Asahi Kasei Medical, the present CEO of Bionova Scientific, Darren Head, will continue to run the company as a business unit.

• February 2022 - A leader in digital care coordination and communication, Vocera Communications, Inc., was acquired by Stryker as part of the previously announced transaction. Vocera's highly complementary and innovative portfolio will boost Stryker's Advanced Digital Healthcare services and further advance Stryker's focus on reducing adverse events in the continuum of care.